heart failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Those who meet the above diagnostic criteria for Western Medicine HFmrEF (NYHA Grade II-III) and TCM Qi-deficiency and blood-stasis syndrome; (2) Age 18-75 years old, male or female; (3) Able to communicate orally and in writing; (4) Those who voluntarily participate in the study, can obey the treatment plan, and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with a history of acute heart failure within the last 30 days; (2) The main right heart dysfunction; (3) Those who are unable to complete the relevant examination of this study due to activities inconvenience or other reasons; (4) Patients with a history of malignant tumor requiring regular radiotherapy and chemotherapy; (5) Patients with rheumatoid arthritis, lupus erythematosus and other diseases, who need to take immunosuppressants regularly; (6) Patients with abnormal liver function (ALT, AST or ALP=3× upper limit of normal); (7) Patients with severe renal insufficiency (estimated glomerular filtration rate eGFR < 30 ml/(min·1.73m2); (8) Obvious hemodynamic changes caused by left ventricular outflow tract obstruction, aortic aneurysm, aortic dissection or unrepaired valve; (9) Patients who are known to be allergic to the drugs or drug ingredients used in this study; (10) Women who are pregnant or planning to become pregnant and breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| nt-probnp; | — |
Secondary
| Measure | Time frame |
|---|---|
| echocardiography;The six-minute walk test;NYHA cardiac function classification;ECG; | — |
Countries
China
Contacts
none